| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100680 | Journal of Crohn's and Colitis | 2010 | 7 Pages |
Abstract
A selected phenotype of Crohn's disease patients may profit from 5-ASA. Fifty-nine percent of patients obtained long-term benefit with 23% becoming 5-ASA dependent. Prospective studies are warranted to assess the role of 5-ASA in Crohn's disease.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Dana Duricova, Natalia Pedersen, Margarita Elkjaer, Jens K. Slott Jensen, Pia Munkholm,